Analysts at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research note issued on Friday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Price Performance
Shares of SRNE opened at $0.01 on Friday. The company’s 50-day moving average is $0.01 and its 200-day moving average is $0.01. Sorrento Therapeutics has a fifty-two week low of $0.00 and a fifty-two week high of $0.25.
About Sorrento Therapeutics
Further Reading
- Five stocks we like better than Sorrento Therapeutics
- How to Effectively Use the MarketBeat Ratings Screener
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- 10 Best Airline Stocks to Buy
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.